Key result
Microplastics in perfusion pose a hidden clinical risk during cardiovascular procedures that necessitates targeted mitigation strategies.
Key points are not available for this paper at this time.
Answers are grounded in this paper and cite their sources.
May indicate unrecognized microplastic risks in perfusion; leaves open whether mitigation improves outcomes.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Friedhelm Beyersdorf (2025) studied this question. Microplastics in perfusion pose a hidden clinical risk during cardiovascular procedures that necessitates targeted mitigation strategies.
Synapse has enriched 10 related papers. Consider them for comparative context: